{"id":"methylphenidate-non-retard","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nervousness"},{"rate":"10-20%","effect":"Insomnia"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Anxiety"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL796","moleculeType":"Small molecule","molecularWeight":"233.31"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved by inhibiting the reuptake of these neurotransmitters, leading to increased activity in the brain. As a result, methylphenidate can help improve attention and reduce impulsivity in individuals with attention deficit hyperactivity disorder (ADHD).","oneSentence":"Methylphenidate is a central nervous system stimulant that works by increasing the levels of dopamine and norepinephrine in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:20:59.883Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Attention deficit hyperactivity disorder (ADHD)"}]},"trialDetails":[{"nctId":"NCT01351272","phase":"PHASE3","title":"Genetic Modulation of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Wuerzburg University Hospital","startDate":"2011-05","conditions":"ADHD","enrollment":41},{"nctId":"NCT02430896","phase":"","title":"Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2015-02","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Methylphenidate, non-retard","genericName":"Methylphenidate, non-retard","companyName":"Wuerzburg University Hospital","companyId":"wuerzburg-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methylphenidate is a central nervous system stimulant that works by increasing the levels of dopamine and norepinephrine in the brain. Used for Attention deficit hyperactivity disorder (ADHD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}